Veza, the Data Security Platform Built on the Power of Authorization, Announces Partnership with Google Cloud
19.7.2022 16:00:00 EEST | Business Wire | Press release
Veza, the data security platform built on the power of authorization, announces today that the company has entered a partnership with Google Cloud, including product integration that enables Google Cloud customers to harness the capabilities of Veza’s data security platform across their multi-cloud ecosystem.
Veza, which recently launched in April 2022 after two years of building in stealth, makes it easy to understand, manage, and control who can and should take what action on what data. With this new integration, Google Cloud customers can now directly access the capabilities of Veza’s authorization-based data security platform integrated with Google Cloud Policy Analyzer to identify, manage, and control external identities and service accounts to Google Cloud services (Looker, BigQuery, and more). This partnership furthers the relationship between Google and Veza, which began in 2021 when GV led the Series B investment in Veza and GV Partner Karim Faris joined Veza Board of Directors.
“The cloud is quickly becoming the primary footprint for organizations. By prioritizing and investing in security, Google Cloud has earned a differentiated position in the market,” said Tarun Thakur, Co-founder and CEO, Veza. “The initial product integration between Veza and Google Cloud, publicly demonstrated at the Google Cloud Security Summit in May this year, is a powerful example of how intelligence from Veza’s Authorization Graph can bolster the data security of Google Cloud customers. It shows how identity-to-data relationship insights from the Veza platform can be pulled directly into the Google Cloud Policy Analyzer, allowing customers to secure both Google Cloud data (Looker, BigQuery, Google Storage Buckets, etc.) to which multi-cloud identities (AD, Azure AD, Okta, etc.) have permissions and multi-cloud data (AWS, Snowflake, etc.) that is being accessed by Google Cloud identities.”
“Securing cloud environments and data from cybercrime and threats is a key priority of organizations across the globe,” said Sunil Potti, General Manager and Vice President, Cloud Security, Google Cloud. “With Veza’s platform now available alongside Google Cloud’s secure and global infrastructure, customers will be able to quickly deploy the solutions they need to better understand, control, and securely take action on their data across their multi-cloud environments.”
Veza’s data security platform aggregates identity information from humans, service accounts, and cloud IAM entities, and authorization data from apps and data systems, giving organizations a centralized, SaaS-based control plane to visualize, manage, and control data access controls through Veza’s Authorization Graph. Veza integrates with cloud identity providers, SaaS and custom apps, and data systems, and translates system-specific entitlements and permissions into a common, human-understandable business language, visualized in the platform as effective permissions. The platform brings a novel approach to data security by enabling organizations to address key data security use cases across access reviews and certifications for SaaS apps and data systems, privileged access management to data and apps, data lake security and governance, management of cloud entitlements, and much more. It delivers prioritized insights, provides access workflows, and actionable recommendations for remediation of over-privileged accounts, enabling security and IT teams to correct anomalies and right-size their organization’s permissions to protect against ransomware and other data breaches.
As organizations continue to adapt to the evolving demands of hybrid remote and in-office work, multi-cloud and hybrid-cloud environments — those with multiple providers of disparate data, app, compute, and infrastructure systems — are becoming the norm. According to the Flexera 2022 State of the Cloud Report, 89% of companies surveyed are multi-cloud, with only 2% operating in single private clouds and 9% in single public clouds. This trend is leading to a distributed web of data, relationships, and access points that are changing and difficult to track and secure.
Veza and Google Cloud already have a number of joint customers deployed across the industries of SaaS software, marketing technology, and media, including Vox Media.
“To support Vox Media’s growth and increasing M&A activity without compromising security, we need to ensure that across all of our brands, the right users have access only to the data they need access to, and that we have full visibility over what they can do with that data,” says Ateeb Ahmad , Senior Director, IT Infrastructure, Vox Media. With Veza and Google Cloud working together, we’ve been able to seamlessly manage access controls over our data for our largest merger to date, and tightly scope identity-to-data permissions even as our footprint with Google Cloud and other technologies grows.”
“The greatest gifts of the multi-cloud and the generational architectural shift of the modern data systems are also its greatest risks: securing data, scalability, flexibility, and seamless collaboration,” says Thakur. “When organizations enable workers to reach from one cloud to another to leverage data across their entire multi-cloud ecosystem, they foster growth, enable more intelligence, and promote agility. However, such apps and data systems are also more porous and are at increased risk of cybercrime and ransomware. We purpose-built Veza’s Core Authorization Platform for the multi-cloud so that organizations can implement strong access governance policies - Veza continuously evaluates these policies and enables both automated workflows for access reviews, automated access removal for toxic and stale combinations, and facilitates access grant and request for any app, data, and service.”
Learn More:
Google Cloud Security Summit - Best practices for defining and enforcing policies across your Google Cloud environment
Veza for Google Cloud demo
Veza for Google Cloud
Veza Free Trial - sign up here
About Veza
Veza is the data security platform built on the power of authorization. Our platform is purpose-built for hybrid multi-cloud environments to help you use and share your data safely. Veza makes it easy to understand, manage, and control who can and should take what action on what data. We organize authorization metadata across identity providers, data systems, cloud service providers, and SaaS applications — all to address the toughest data security challenges of the modern era. Founded in 2020, the company is funded by top-tier investors including Accel, Bain Capital, Ballistic Ventures, Blackstone, GV, Norwest Venture Partners, and True Ventures. To learn more, please visit us at veza.com. You can follow us on LinkedIn or on Twitter @vezainc.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220719005324/en/
Contact information
Aircover PR
veza@aircoverpr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 01:10:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of ORZEYFUL marks a new chapter for the narcolepsy type 1 community, as we introduce an entirely new class of medicine that will potentially redefine how this disease is managed and howpeople feel on treatment,” said Julie Kim, president and chief executive officer of Takeda. “We are proud to have discovered and developed this orexin treatment innovation and will bring it to adults living with NT1 as quickly as possible.” NT1 is a rare, chronic neurological disease d
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 23:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 17:05:00 EEST | Press release
Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership, and operational excellence with a track record of execution from first-in-human studies through regulatory
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 17:00:00 EEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
Speech Processing Solutions Launches Philips SpeechLive Legal AI Assistant for Faster, More Accurate Legal Document Creation5.8.2026 16:37:00 EEST | Press release
Speech Processing Solutions, the global leader in AI-assisted professional dictation and documentation solutions sold under the Philips brand, today announced the Philips SpeechLive Legal AI Assistant. The new solution transforms voice recordings, dictation and uploaded sources into structured, ready-to-review legal documents, helping legal professionals work faster while retaining control of the final draft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805997413/en/ The new Philips SpeechLive Legal AI Assistant is designed for turning conversations into ready-to-review legal document drafts. SpeechLive Legal significantly reduces the time needed to transform voice input into structured legal documentation, delivering consistent and high-quality drafts and featuring SpeechLive's built-in integrations with leading case management platforms such as Actionstep, Clio, iManage and NetDocuments, supporting existing billing, e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
